Takeda’s zasocitinib has shown strong rates of skin clearance, as well as other benefits, in new study results regarding ...

Approximately 20% to 30% of all people who suffer from psoriasis also develop painful inflammation in their joints over time.

Scalp flaking seems harmless and picking the scabs can even be satisfying for many. However, it may signal more serious ...

The Authority held that treatment of psoriasis, dermatitis, fungal infections, and similar conditions constitutes healthcare ...

The psoriasis market is experiencing steady growth, driven by rising disease prevalence, improved diagnosis rates, and greater patient access to advanced therapies. The shift from conventional ...

The psoriasis market is experiencing steady growth, driven by rising disease prevalence, improved diagnosis rates, and ...

Sun Pharma Canada Inc., a wholly owned subsidiary of Sun Pharmaceutical Industries Limited ("Sun Pharma"), is pleased to announce the availability of ILUMYA (tildrakizumab) Pen, a self-administered ...

Psoriasis is a chronic, recurrent, and incurable autoimmune disease in which the body mistakenly attacks its own tissue, ...

Both Phase 3 trials met all primary and secondary endpoints with high statistical significance in patients with moderate-to-severe plaque ...

Hair fall, which has become increasingly common, can be quite scary when it is persistent or excessive. While it may point to ...

If you grew up in an Indian household, you’ve heard this at least a hundred times: “Geelay baal ke saath mat baitho” or ...